Suven Life Sciences Limited (SUVEN) — Announcement | 13 May 2026
Suven Life Sciences announced on May 13, 2026 that its Nomination & Remuneration Committee approved the grant of 1,33,200 stock options under the Suven Life Sciences Limited – Employee Stock Option Scheme 2020 to eligible employees, with an exercise price of ₹55 per option and vesting over three years starting May 13, 2027.
About Suven Life Sciences Limited (SUVEN)
Healthcare · Healthcare · Listed on NSE
📡 Get AI alerts when SUVEN files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track SUVEN — Free💡 Ask AI about this filing
📊 More SUVEN filings
- Announcement — 28 September 2026Suven Life Sciences announced that its trading window will close on 1 October 2026, remaining shut f...
- 🔴 Announcement — 3 September 2026Suven Life Sciences announced completion of patient enrollment in its global Phase-3 Masupirdine tri...
- Announcement — 11 August 2026Suven Life Sciences disclosed a CRISIL Monitoring Agency Report for the quarter ended June 30, 2026,...
- 🟡 Board Meeting — 6 August 2026Suven Life Sciences announced unaudited standalone and consolidated financial results for Q1 FY2026,...
- 🔴 Annual Report — 30 July 2026Suven Life Sciences held its 37th Annual General Meeting on August 25, 2026 via video conference, ap...
🔥 Also filed on 13 May 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when SUVEN files new disclosures
Track SUVEN filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SUVEN — FreeFree account · 2 AI queries/day